Latest medical news · page 76

What You May Have Missed in 2024: Part 3

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."

Episode 240 -- October 2025 -- Part 2 AFP: American Family Physician

Overuse of colorectal cancer screening (1:30), depression practice guideline (3:20), anticoagulation in hospitalized patients with COVID-19 (6:10), slipped capital femoral epiphysis (7:50), left atrial appendage closure in atrial fibrillation after ablation (11:30), and venous thromboembolism (14:00).

Episode 67 - Angeliki Melidou - Winter Viruses: The triple threat explained

In this episode of ECDC On Air, we discuss the seasonal spread of respiratory viruses with ECDC's Principal Expert in Respiratory Viruses - Angeliki Melidou. Angeliki explores the impact of viruses like influenza, RSV, and COVID-19, the importance of vaccination, and practical measures to protect both individuals and healthcare systems. Tune in for insights on how to navigate the winter months safely. Read about the current respiratory disease situation on erviss.org . For more information about ECDC in general visit ecdc.europa.eu and follow our social media for the latest news.

FDA expands Vyepti (eptinezumab-jjmr) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Lundbeck Seattle Biopharmaceuticals, Inc.

What You May Have Missed in 2024 - Part 2

Dr. Centor revisits information included in the Annals of Internal Medicine supplement "What You May Have Missed in 2024."

4 takeaways from the AAFP’s response to the 2026 MPFS proposed rule

Episode 239 -- October 2025 -- Part 1 AFP: American Family Physician

Uterine fibroids (1:30), community-based residency training (6:40), glucagon-like peptide-1 medications (9:00), heart failure with preserved ejection fraction (12:30), intravenous vs oral iron (15:40), nicotine e-cigarettes for smoking cessation (18:10), and spooky health trends—are they real or fake? (20:10; music: Tocatta and Fugue in D Minor, Kevin MacLeod, CC-BY-3.0).

AAFP CME earns special accreditation again—why that matters

Domino dazzles with another rundown of latest medical research

‘Chaos is an opportunity to do right by the world,’ says FMX speaker

Surgeon General Murthy emphasizes community in FMX fireside chat

High-Concentration Cannabinoids: Are They Safe?

Dr. Centor discusses currently available evidence about high-concentration cannabis products and mental health outcomes with Drs. Paula Riggs and Jonathan Samet.

Suite of new physician leaders elected at 2025 Congress of Delegates

Congress of Delegates adopts measures to strengthen physicians and patient health

FDA expands Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Genentech Inc

FDA expands Tecentriq (atezolizumab) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Genentech Inc

Academy objects to visa changes limiting primary care workforce

Make the most out of FMX

Federal government shutdown: What family physicians need to know—and do

Episode 238 -- September 2025 -- Part 2 AFP: American Family Physician

Lymphadenopathy (1:30), galantamine for dementia (5:30), parenteral agents for migraines (7:30), EpiSwitch prostate cancer screening test (10:40), vitamin B12 deficiency (14:00), and fezolinetant for menopause (17:40).

FDA expands Tremfya (guselkumab) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Janssen Biotech

FDA expands Tremfya (guselkumab) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Janssen Biotech

FDA expands Tremfya (guselkumab) approval

Efficacy supplement (new or revised indication). injectable, injection. Sponsor: Janssen Biotech

FDA approves Keytruda Qlex (pembrolizumab, berahyaluronidase alfa-pmph)

Original biologic license approval. injectable, injection. Sponsor: Merck Sharp Dohme